A SARS-CoV-2 serological assay to determine the presence of blocking antibodies that compete for human ACE2 binding

As SARS-CoV-2 continues to spread around the world, there is an urgent need for new assay formats to characterize the humoral response to infection. Convalescent serum is being used for treatment and for isolation of patient-derived antibodies. However, currently there is not a simple means to estim...

Descripción completa

Detalles Bibliográficos
Autores principales: Byrnes, James R., Zhou, Xin X., Lui, Irene, Elledge, Susanna K., Glasgow, Jeff E., Lim, Shion A., Loudermilk, Rita, Chiu, Charles Y., Wilson, Michael R., Leung, Kevin K., Wells, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273274/
https://www.ncbi.nlm.nih.gov/pubmed/32511506
http://dx.doi.org/10.1101/2020.05.27.20114652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273274/
https://www.ncbi.nlm.nih.gov/pubmed/32511506
http://dx.doi.org/10.1101/2020.05.27.20114652

Ejemplares similares